What 4 Analyst Ratings Have To Say About HealthEquity
Portfolio Pulse from Benzinga Insights
Over the past 3 months, 4 Wall Street analysts have published somewhat bullish opinions on HealthEquity (NASDAQ:HQY) with an average price target of $84.5, representing an implied upside from the current price of $69.53. The current average price target has increased by 1.81% from the previous target of $83.00. Analysts typically review stocks quarterly or after major company updates, using financial analysis and insider information to provide guidance to investors.
December 06, 2023 | 6:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
HealthEquity (HQY) has received somewhat bullish ratings from 4 analysts with an average price target of $84.5, indicating a potential upside from its current price of $69.53.
The unanimous somewhat bullish sentiment from analysts and the increase in the average price target suggest a positive outlook for HQY stock in the short term. As analysts' ratings can influence market perception and investor behavior, this consensus could lead to an increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100